Heart Disease Trial, Recruiting NCT07060937 Sponsor: Riphah International University Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07060937
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 30 and 50 years old
  • People who have had heart bypass surgery (called CABG)
  • Both men and women are eligible
  • People who are able to move around (mobile) after their surgery
  • People who are on day 3 or day 5 of recovery after their bypass surgery

Who may not be able to join:

  • People who have experienced harmful side effects or complications (adverse events) after surgery
  • People whose heart and blood pressure are not stable
  • People who have a recorded diagnosis of cognitive dysfunction (problems with memory or thinking)
  • People who have a neurological or musculoskeletal condition — other than osteoarthritis — that affects how they walk or bear weight
  • People with serious other health conditions, repeated health episodes, or an unstable overall health condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Suman Sheraz, PhD, Riphah International University

Phone: 923335646361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
30 March 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Time up and go test; Five times sit to stand test; 2 Minute walk test; 6 Minute walk test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov